Brainomix unveils Next-Gen AI Software for CT Stroke Detection
Published: 10 Feb 2026
Author: Precedence Research
Brainomix, a world leader in AI powered medical imaging market is all set to launch its latest Brainomix 360 Stroke Next Generation software at the International Stroke Conference to be held from February 4-6, 2026, in New Orleans. This advanced technology aims to enhance the diagnostic capabilities of acute stroke detection using routine non-contrast CT scans. This helps doctors to take informed decisions about treatment at the right time.
One of the most notable features in the new software is the automated net water uptake(NWU), a CT biomarker that helps measure the severity of tissue injury and edema in acute strokes. This is the first time that such a feature has been introduced in the industry. This feature will help doctors gain more prognostic information about patients, especially in settings where advanced imaging tools are not available. According to Dr. George Harston, Chief Medical and Innovation Officer at Brainomix, NWU enhances the existing capabilities of ischemic core volume and e-ASPECTS. This facilitates doctors to derive more insights from routine CT scans.
Apart from NWU, the upgrade also features improved DICOM viewing tools and AI-based analytics that optimize CT scan workflows enabling radiologists and stroke teams to quickly analyze images. According to Brainomix, these new technologies could help make faster, more confident decisions about stroke treatment which will result in outcome improvement. At ISC, the firm will also showcase a number of research abstracts that demonstrate the clinical benefit and cost effectiveness of its platform, further validating the role of AI in stroke treatment. This new technology represents a major milestone in integration of AI with stroke diagnostics with the potential to improve care delivery even in resource strained regions.